1-2 of 2
Mark D. Carpenter
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects

Carmelo Blanquicett, M. Wasif Saif, Donald J. Buchsbaum, Mohamad Eloubeidi, Selwyn M. Vickers, David C. Chhieng, Mark D. Carpenter, Jeffrey C. Sellers, Suzanne Russo, Robert B. Diasio, Martin R. Johnson
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (24): 8773–8781.
https://doi.org/10.1158/1078-0432.CCR-05-0627
Published: 16 December 2005
View articletitled, Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects
Open the PDF for Antitumor Efficacy of Capecitabine and Celecoxib in Irradiated and Lead-Shielded, Contralateral Human BxPC-3 Pancreatic Cancer Xenografts: Clinical Implications of Abscopal Effects in another window
Journal Articles

A Phase I Study of Anti-Kinase Insert Domain-containing Receptor Antibody, IMC-1C11, in Patients with Liver Metastases from Colorectal Carcinoma

James A. Posey, Thian C. Ng, Baolian Yang, M. B. Khazaeli, Mark D. Carpenter, Floyd Fox, Mike Needle, Harlan Waksal, Albert F. LoBuglio
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (4): 1323–1332.
Published: 01 April 2003
View articletitled, A Phase I Study of Anti-Kinase Insert Domain-containing Receptor Antibody, IMC-1C11, in Patients with Liver Metastases from Colorectal Carcinoma
Open the PDF for A Phase I Study of Anti-Kinase Insert Domain-containing Receptor Antibody, IMC-1C11, in Patients with Liver Metastases from Colorectal Carcinoma in another window